Literature DB >> 33986027

Socioeconomic biases in asthma control and specialist referral of possible severe asthma.

Kjell Erik Julius Håkansson1, Vibeke Backer2,3,4, Charlotte Suppli Ulrik5,4.   

Abstract

BACKGROUND: Although socioeconomic impact on asthma control has been investigated, little is known about its relationship to specialist referral of patients with possible severe asthma, especially in a public healthcare setting. The present study aims to identify socioeconomic patterns in disease control and referral of patients with asthma in a nationwide cohort of adult patients treated with inhaled corticosteroids (ICS).
METHODS: Asthma patients fulfilling the following criteria were included: aged 18-45 years and redeeming two or more prescriptions of ICS during 2014-2018 based on data from Danish national registers. Possible severe asthma was defined as Global Initiative for Asthma 2020 step 4 (with either two or more courses of systemic steroids or at least one hospitalisation) or step 5 treatment. Findings presented as odds ratios (95% confidence intervals).
RESULTS: Out of 60 534 patients (median age 34 years, 55% female), 3275 (5.7%) were deemed as having possible severe asthma, of whom 61% were managed in primary care alone. Odds of specialist management for possible severe asthma decreased with age (OR 0.66, 95% CI 0.51-0.85; 36-45 versus 18-25 years), male sex (OR 0.75, 95% CI 0.64-0.87), residence outside the Capital Region (OR 0.70, 95% CI 0.59-0.82) and with receiving unemployment or disability benefits (OR 0.75, 95% CI 0.59-0.95). Completion of higher education increased odds of specialist referral (OR 1.28, 95% CI 1.03-1.59), when compared to patients with basic education.
CONCLUSION: Even in settings with nationally available free access to specialist care, the majority of patients with possible severe asthma are managed in primary care. Referral of at-risk asthma patients differs across socioeconomic parameters, calling for initiatives to identify and actively refer these patients.
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33986027     DOI: 10.1183/13993003.00741-2021

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  High Use of Antidepressant Medication in Both Mild-to-Modelate and Possible Severe Asthma - A Nationwide Cohort Study.

Authors:  Kjell Erik Julius Håkansson; Martino Renzi-Lomholt; Vibeke Backer; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2022-01-05

2.  Disease Control, Not Severity, Drives Job Absenteeism in Young Adults with Asthma - A Nationwide Cohort Study.

Authors:  Kjell Erik Julius Håkansson; Vibeke Backer; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2022-06-20

3.  Trends and predictors of specialist assessments in oral corticosteroid treated asthma among young adults.

Authors:  Inge Raadal Skov; Hanne Madsen; Jacob Harbo Andersen; Anton Pottegård; Jesper Rømhild Davidsen
Journal:  ERJ Open Res       Date:  2022-07-25

4.  Socioeconomic status is associated with healthcare seeking behaviour and disease burden in young adults with asthma - A nationwide cohort study.

Authors:  Kjell Erik Julius Håkansson; Vibeke Backer; Charlotte Suppli Ulrik
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

5.  Determinants of Severe Asthma - A Long-Term Cohort Study in Northern Sweden.

Authors:  Helena Backman; Caroline Stridsman; Linnea Hedman; Lina Rönnebjerg; Bright I Nwaru; Thomas Sandström; Hannu Kankaanranta; Anne Lindberg; Eva Rönmark
Journal:  J Asthma Allergy       Date:  2022-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.